Hi, what are you looking for?
Jewish Business News
Search results for "Perrigo"
Business
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
World News
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Business
Kenalog® Spray annual sales were approximately $16 million according to IMS Health.
Business
Israel’s Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver...
Business
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
IPOs
– The company will use the offering to help finance the $4.5 billion acquisition of Omega Pharma. OTC pharmaceutical company Perrigo Company (NYSE:PRGO; TASE:PRGO)...
Business
– Perrigo is expanding its reach into Europe through a $3.1 billion acquisition of one of the continent’s biggest suppliers of non-prescription medicines....
Business
– The generic drug company’s fourth quarter results beat analysts’ estimates. Perrigo Company (NYSE:PRGO; TASE:PRGO) released its fourth quarter and full year results today....